Central - Tenders Closing for a specific Date

Report For Day : 16-Apr-2026

Total Tenders : 1682
Sl.No e-Published Date Bid Submission Closing Date Tender Opening Date Title/Ref.No./Tender Id State Name Corrigendum
161. 31-Mar-2026 11:40 AM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM HYB DIVISION_MEDICAL_SURGICAL(PH NO. : 63060) SELF ADHESIVE WOUND DRESSING 25 CM X 10 CM (PACK OF 20)/82264905/107010658 Ministry of Railways --
162. 31-Mar-2026 11:42 AM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM HYB DIVISION_MEDICAL_SURGICAL (PH NO.:42685) SPLINTS WOODEN (SET OF 6)/82263618/107010664 Ministry of Railways --
163. 03-Apr-2026 03:07 PM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM GTL_MEDICAL_PH.No.40230_SURGICAL_NUTRIENT AGAR 500 G/82263203/107014317 Ministry of Railways --
164. 31-Mar-2026 02:07 PM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM Tube/LN261246/107010899 Ministry of Railways --
165. 25-Mar-2026 03:16 PM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM SERVOPLEX SHC-120/06261137/107001485 Ministry of Railways --
166. 31-Mar-2026 02:32 PM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM GTL_MEDICAl_PH.No.22126 _MEDICINE_AMBRISENTAN 5 MG TAB/CAP./82261742B/107010933 Ministry of Railways --
167. 31-Mar-2026 04:10 PM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM HYB-MEDICAL-DRUGS (PH NO.:25033) GEFITINIB 250 MG TAB/82262651/107011103 Ministry of Railways --
168. 31-Mar-2026 04:12 PM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM HYB-MEDICAL-DRUGS PH:.(49089)Silver Sulfadiazine (Nanonized) 0.5 Percent w/w + Chlorhexidine Gluconate 0.2 Percent w/w Cream - pack size between 10 gm to 20 gm, rate reasonability quoted per gm/82264920B/107011108 Ministry of Railways --
169. 26-Mar-2026 10:37 AM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM HYB-MEDICAL-DRUGS (PH NO.:10065) SAXAGLIPTIN 5 MG TAB/82261451B/107006605 Ministry of Railways --
170. 26-Mar-2026 10:39 AM 16-Apr-2026 10:30 AM 16-Apr-2026 10:30 AM HYB-MEDICAL-DRUGS (PH NO.:06119) CEFPODOXIME PROXETIL 50 MG/ 5 ML SYP - 30 ML/82261275D/107006609 Ministry of Railways --

Note : For more details and clarifications, please refer to the respective Portal.